A conundrum in cancer quality measurement: Performance on long-term survival reflects performance a long time ago.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e18222-e18222
Author(s):  
Allison Lipitz-Snyderman ◽  
Michael A. Curry ◽  
David M. Rubin ◽  
Diane G. Li ◽  
Elaine Duck ◽  
...  

e18222 Background: Long term outcomes, such as five-year survival following cancer treatment, are widely accepted as important metrics of cancer care quality. But because they take years to accrue, they reflect the quality of care delivered in the past. The objective of this study was to delineate to what extent measures of long term outcomes related to cancer care could be reliably used to predict care quality in future periods. Methods: Taking advantage of FFS Medicare data from related studies, we assessed survival of cancer patients at one and four years by hospital for four separate index years 2006, 2011-2013. We assembled pairs of years across which we could compare risk adjusted outcomes separated by one year (2011 to 2012; 2012 to 2013), two years (2011 to 2013), and five through seven years comparing 2006 to 2011, 2012, or 2013 respectively. The outcome was risk adjusted mortality rates at the hospital level determined by dividing the observed number of deaths by an expected number, adjusting for age, and median income level of the zip code of residence. For each hospital and for every pair of analytic years we separately compared the correlation of one and four-year risk adjusted mortality using both Pearson and Spearman correlation statistics. A mixed effects model was fit to determine if size and year gap between measurements could explain possible differences in the correlation of hospital performance, while controlling for hospitals as a random effect. Results: There were 1,640 hospitals and more than 350,000 patients in each analysis year. Focusing on the correlation of the four year survival outcomes, the highest volume hospitals have significantly higher correlations compared to the other hospital categories (P < 0.001). The greater the elapsed time between measurement periods the lower the correlation. But in the mixed model analysis neither time elapsed between measurement periods (p = 0.51) nor the interaction between time elapsed and hospital volume (p = 0.95) were significant. Analyses of one-year outcomes produced similar findings. Conclusions: Performance on four-year survival outcomes of cancer patients was reasonably correlated for large volume hospitals, but less so for hospitals with lower volumes.

2010 ◽  
Vol 2010 ◽  
pp. 1-9 ◽  
Author(s):  
Tosin Ajala ◽  
Junaid Rafi ◽  
Peter Larsen-Disney ◽  
Richard Howell

Infertility can arise as a consequence of treatment of oncological conditions. The parallel and continued improvement in both the management of oncology and fertility cases in recent times has brought to the fore-front the potential for fertility preservation in patients being treated for cancer. Oncologists must be aware of situations where their treatment will affect fertility in patients who are being treated for cancer and they must also be aware of the pathways available for procedures such as cryopreservation of gametes and/or embryos. Improved cancer care associated with increased cure rates and long term survival, coupled with advances in fertility treatment means that it is now imperative that fertility preservation is considered as part of the care offered to these patients. This can only be approached within a multidisciplinary setting. There are obvious challenges that still remain to be resolved, especially in the area of fertility preservation in prepubertal patients. These include ethical issues, such as valid consent and research in the area of tissue retrieval, cryopreservation, and transplantation.


Author(s):  
Zheng-Yan Li ◽  
Jie Chen ◽  
Bin Bai ◽  
Shuai Xu ◽  
Dan Song ◽  
...  

Abstract Background The benefits of laparoscopic gastrectomy (LG) in elderly gastric-cancer patients still remain unclear. The purpose of this study was to evaluate the feasibility and safety of LG in elderly gastric-cancer patients. Methods We retrospectively evaluated patients who underwent LG or open gastrectomy (OG) between June 2009 and July 2015 in a single high-volume center. We compared surgical, short-term, and long-term survival outcomes among an elderly (≥70 years old) LG (ELG) group (n = 114), a non-elderly (&lt;70 years old) LG (NLG) group (n = 740), and an elderly OG (EOG) group (n = 383). Results Except for extended time to first flatus, the surgical and short-term outcomes of the ELG group were similar to those of the NLG group. The ELG group revealed comparable disease-specific survival (DSS) rates to the NLG group (64.9% vs 66.2%, P = 0.476), although the overall survival (OS) rate was lower (57.0% vs 65.5%, P &lt; 0.001) in the ELG group than in the NLG group. The ELG group showed longer operation time than the EOG group (236.4 ± 77.3 vs 179 ± 52.2 min, P &lt; 0.001). The ELG group had less estimated blood loss (174.0 ± 88.4 vs 209.3 ± 133.8, P = 0.008) and shorter post-operative hospital stay (8.3 ± 2.5 vs 9.2 ± 4.5, P = 0.048) than the EOG group. The severity of complications was similar between the ELG and NLG groups. Multivariate analysis confirmed that LG was not a risk factor for post-operative complications. Conclusions LG is a feasible and safe procedure for elderly patients with acceptable short- and long-term survival outcomes.


2011 ◽  
Vol 11 ◽  
pp. 1560-1567 ◽  
Author(s):  
Henry M. Rosevear ◽  
Andrew J. Lightfoot ◽  
Michael A. O'Donnell ◽  
Charles E. Platz ◽  
Stefan A. Loening ◽  
...  

In the early 1950s, Rubin H. Flocks of the University of Iowa began to treat prostate cancer patients with colloidal gold (Au198) therapy, evolving his technique over nearly 25 years in 1515 patients. We reviewed the long-term outcomes of Flocks' prostate cancer patients as compared to those patients treated by other methods at the University of Iowa before Flocks' chairmanship. We reviewed archived patient records, Flocks' published data, and long-term survival data from the Iowa Tumor Registry to determine short- and long-term outcomes of Flocks' work with colloidal gold. We also reviewed the literature of Flocks' time to compare his outcomes against those of his contemporaries. The use of colloidal gold, either as primary or adjunctive therapy, provided short- and long-term survival benefit for the majority of Flocks' patients as compared to historical treatment options (p< 0.001). Flocks' use of colloidal gold for the treatment of locally advanced prostate cancer offered short- and long-term survival benefits compared to other contemporary treatments.


Sign in / Sign up

Export Citation Format

Share Document